Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
McGuire, Philip K.
Jones, Peter
Harvey, Ian
Bebbington, Paul
Toone, Brian
Lewis, Shôn
and
Murray, Robin M.
1994.
Cannabis and acute psychosis.
Schizophrenia Research,
Vol. 13,
Issue. 2,
p.
161.
Green, A. R.
Cross, A. J.
and
Goodwin, G. M.
1995.
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”).
Psychopharmacology,
Vol. 119,
Issue. 3,
p.
247.
Madden, John S.
1995.
Pharmacodynamics and pharmacokinetics of alcohol and drugs.
Current Opinion in Psychiatry,
Vol. 8,
Issue. 3,
p.
195.
Grob, Charles S.
Poland, Russell E.
Chang, Linda
and
Ernst, Thomas
1995.
Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations.
Behavioural Brain Research,
Vol. 73,
Issue. 1-2,
p.
103.
Seivewright, Nicholas
and
McMahon, Charles
1996.
Misuse of amphetamines and related drugs.
Advances in Psychiatric Treatment,
Vol. 2,
Issue. 5,
p.
211.
Henry, J A
1996.
Management of drug abuse emergencies..
Emergency Medicine Journal,
Vol. 13,
Issue. 6,
p.
370.
Obradovic, T
Imel, K.M
and
White, S.R
1996.
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine.
Neuroscience,
Vol. 74,
Issue. 2,
p.
469.
Henry, JohnA.
1996.
Ecstasy and serotonin depletion.
The Lancet,
Vol. 347,
Issue. 9004,
p.
833.
Poole, Rob
and
Brabbins, Clare
1996.
Drug Induced Psychosis.
British Journal of Psychiatry,
Vol. 168,
Issue. 2,
p.
135.
Yau, J.L.W
Noble, J
and
Seckl, J.R
1997.
Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: role of corticosterone and serotonin.
Neuroscience,
Vol. 78,
Issue. 1,
p.
111.
Spatt, J
Glawar, B
and
Mamoli, B
1997.
A pure amnestic syndrome after MDMA ("ecstasy") ingestion..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 62,
Issue. 4,
p.
418.
McCann, Una D.
Lowe, Kelly A.
and
Ricaurte, George A.
1997.
REVIEW ■ : Long-lasting Effects of Recreational Drugs of Abuse on the Central Nervous System.
The Neuroscientist,
Vol. 3,
Issue. 6,
p.
399.
Barone, Joseph A.
and
Shermock, Kenneth M.
1997.
Designer Drugs of Abuse.
Journal of Pharmacy Practice,
Vol. 10,
Issue. 4,
p.
292.
CURRAN, H. VALERIE
and
TRAVILL, ROSS A.
1997.
Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low.
Addiction,
Vol. 92,
Issue. 7,
p.
821.
Schwartz, Richard H.
and
Miller, Norman S.
1997.
MDMA (Ecstasy) and the Rave: A Review.
Pediatrics,
Vol. 100,
Issue. 4,
p.
705.
Huether, G.
Zhou, D.
and
R�ther, E.
1997.
Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its congeners.
Journal of Neural Transmission,
Vol. 104,
Issue. 8-9,
p.
771.
1998.
Proceedings of the British Toxicology Society Annual Congress University of Surrey, Guildford 19 - 22 April 1998.
Human & Experimental Toxicology,
Vol. 17,
Issue. 9,
p.
469.
McCann, Una D.
Mertl, Melissa
and
Ricaurte, George A.
1998.
Handbook of Substance Abuse.
p.
567.
Windhaber, Johann
Maierhofer, Dagmar
and
Dantendorfer, Karl
1998.
Panic Disorder Induced by Large Doses of 3,4-Methylenedioxymethamphetamine Resolved by Paroxetine.
Journal of Clinical Psychopharmacology,
Vol. 18,
Issue. 1,
p.
95.
Ferigolo, Maristela
Medeiros, Fernanda B.
and
Barros, Helena M. T.
1998.
"Êxtase": revisão farmacológica.
Revista de Saúde Pública,
Vol. 32,
Issue. 5,
p.
487.
eLetters
No eLetters have been published for this article.